Home » Alexion Buys Taligen for $111 Million
Alexion Buys Taligen for $111 Million
Cheshire, CT-based Alexion Pharmaceuticals has bought Cambridge, MA, biotech startup [Taligen] for $111 million and potential future payments, the buyer said Tuesday.
Xconomy
Xconomy
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May